ER+/HER2-21

Yang Chen1,2, Lizhi Xie3, Wei Tang1,2

  • 1Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.

Cancer medicine
|September 2, 2025
PubMed
概括

可预测ER+/HER2乳腺癌的复发风险,为年轻女性的治疗决策提供了代价昂贵的基因测试的潜在替代方案.